Direkt zum Inhalt
Merck

Analysis of protein prenylation in vitro and in vivo using functionalized phosphoisoprenoids.

Current protocols in protein science (2010-11-26)
Uyen T T Nguyen, Yaowen Wu, Andrew Goodall, Kirill Alexandrov
ZUSAMMENFASSUNG

Post-translational modifications (PTMs) expand the number of protein isoforms in eukaryotic proteome by orders of magnitude. Protein modification with isoprenoid lipids is a common PTM affecting hundreds of proteins controlling the transport of information and materials into, through, and out of the eukaryotic cell. In this modification, a soluble phosphoisoprenoid such as farnesyl (C15) or geranylgeranyl (C20) pyrophosphate moiety is recruited by one of three protein prenyltransferases to covalently modify a C-terminal cysteine(s) in a target protein. The three mammalian prenyltransferases are farnesyltransferase (FTase), geranylgeranyltransferase type I (GGTase I), and Rab geranylgeranyl transferase (also termed geranylgeranyltransferase type II - GGTase II). In this unit, synthetic isoprenoids conjugated to either a fluorophore or biotin group are used to assay the activity of protein prenyltransferases in vitro or to affinity tag prenylatable proteins in cell lysates. These protocols and their modifications can be used to study the mechanisms of protein prenylation, identify prenylation targets, and characterize inhibitors of protein prenyltransferases in vitro and in vivo.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Roche
cOmplete, Mini, EDTA-freier Protease-Inhibitor-Cocktail, Protease Inhibitor Cocktail Tablets provided in a glass vial, Tablets provided in a glass vial
Roche
Chymotrypsin in Sequenzierqualität, from bovine pancreas